Evidently, there are many reports demonstrating that drug chemical delivery for brain tumors could be induced through the regulation of ABC transporter activity, thus suggesting the potential for the control of ABC transporter activity to control drug efficiency. Here, ABCG2 is linked to brain neoplasm.